Loading...

Myovant Sciences Ltd.

MYOVNYSE
Healthcare
Biotechnology
$26.98
$-0.01(-0.04%)

Myovant Sciences Ltd. (MYOV) Stock Overview

Explore Myovant Sciences Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 67.0/100

Key Financials

Market Cap2.6B
P/E Ratio-12.18
EPS (TTM)$-1.92
ROE0.50%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$46.07

MYOV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Myovant Sciences Ltd. (MYOV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $46.07.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -12.18 and a market capitalization of 2.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;